This molecule was part of a large library of triazole-modified alginates developed by researchers at MIT and Boston Children's Hospital. The goal was to find a coating that would allow implanted medical devices or encapsulated cells (like those used for Type 1 Diabetes treatment) to function inside the body without being attacked by the immune system. Key Findings for 287_63
"287_63" refers to a specific chemical identifier—specifically —used in groundbreaking research on modified alginate polymers to prevent the foreign body response (fibrosis) in medical implants. Research Context 287_63
: It is a triazole-based modification of alginate, specifically created through "click chemistry" to change the surface properties of the polymer. This molecule was part of a large library
: Highly cited papers in Nature Medicine and Nature Biotechnology (circa 2016) by the Anderson and Langer labs. Research Context : It is a triazole-based modification